Related Experiment Video
Updated: Apr 10, 2026

Identification and Characterization of Immunogenic RNA Species in HDM Allergens that Modulate Eosinophilic Lung Inflammation
Published on: May 30, 2020
PM2.5 exacerbates house dust mite-induced allergic rhinitis via STING-mediated nasal epithelial barrier disruption
Youwei Bao1,2, Zhiqiang Zhang1,2, Qi Chen1,2
1Department of Otorhinolaryngology Head and Neck Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.
Background:
The synergistic effect of PM2.5 and house dust mite (HDM) in exacerbating allergic rhinitis (AR) is recognized, but the underlying molecular mechanisms remain unclear.
Objective:
This study investigated whether PM2.5 aggravates HDM-induced AR and nasal epithelial barrier damage via the STING signaling pathway.
Methods:
This research combined bioinformatics analysis of a human nasal transcriptome dataset with in vivo (BALB/c mouse model) and in vitro (Human Nasal Epithelial Cells, HNEpCs) experiments. Models were exposed to PM2.5 and HDM, alone or in combination. Rhinitis symptoms, epithelial barrier integrity, Th2 inflammation, and the STING/NF-κB pathway were assessed. The STING inhibitor H-151 was used for functional validation.
Results:
Bioinformatics analysis linked PM2.5 exposure to TNF/NF-κB signaling. In vivo and in vitro experiments consistently demonstrated that co-exposure to PM2.5 and HDM synergistically worsened nasal symptoms, Th2 responses (elevated IL-4, IL-5, IL-13, IgE), and impaired barrier function (downregulated E-cadherin and Claudin-1), while activating the STING/NF-κB pathway. Critically, H-151 treatment reversed these pathological changes.
Conclusion:
PM2.5 disrupts the nasal epithelial barrier and synergizes with HDM to exacerbate allergic inflammation by activating the STING/NF-κB pathway. This study identifies STING as a potential therapeutic target for environment-aggravated allergic diseases.
Insights
Particulate matter (PM2.5) and house dust mite (HDM) worsen allergic rhinitis by damaging nasal barriers and activating the STING/NF-κB pathway. Targeting STING may treat environment-aggravated allergies.
Area of Science:
- Environmental Health
- Immunology
- Molecular Biology
Background:
- The combined impact of PM2.5 and house dust mite (HDM) on allergic rhinitis (AR) is known, but molecular mechanisms are unclear.
- PM2.5 is a common air pollutant, and HDM is a major indoor allergen.
- Understanding their interaction is crucial for managing AR.
Purpose of the Study:
- To investigate if PM2.5 exacerbates HDM-induced AR and nasal epithelial barrier damage.
- To determine the role of the STING signaling pathway in this process.
- To identify potential therapeutic targets for environmentally aggravated allergic diseases.
Main Methods:
- Bioinformatics analysis of human nasal transcriptome data.
- In vivo studies using a BALB/c mouse model.
- In vitro experiments with Human Nasal Epithelial Cells (HNEpCs) exposed to PM2.5 and HDM, alone and combined.
- Assessment of rhinitis symptoms, epithelial barrier integrity, Th2 inflammation, and the STING/NF-κB pathway.
- Functional validation using a STING inhibitor (H-151).
Main Results:
- PM2.5 exposure was linked to TNF/NF-κB signaling via bioinformatics.
- Co-exposure to PM2.5 and HDM synergistically worsened nasal symptoms and Th2 responses (increased IL-4, IL-5, IL-13, IgE).
- Epithelial barrier function was impaired (decreased E-cadherin, Claudin-1), and the STING/NF-κB pathway was activated.
- STING inhibitor H-151 reversed these pathological changes.
Conclusions:
- PM2.5 disrupts the nasal epithelial barrier and exacerbates HDM-induced allergic inflammation.
- Activation of the STING/NF-κB pathway is a key mechanism in this synergistic effect.
- STING represents a potential therapeutic target for allergic diseases aggravated by environmental factors.
More Related Videos
Related Concept Videos
Allergic Reactions
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-I: Introduction
Allergic Reactions: Anaphylaxis

